Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 06 July 2021
Sec. Cardiovascular Epidemiology and Prevention
Volume 8 - 2021 | https://doi.org/10.3389/fcvm.2021.723626
This article is part of the Research Topic Renal Function and Related Biomarkers in Cardiovascular Risk Assessment and Prevention View all 8 articles

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

This article is a correction to:

  1. Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

    1. Read original article
\nHangying YingHangying Ying1Hongdi YuanHongdi Yuan2Xiaomei TangXiaomei Tang1Wenpu GuoWenpu Guo1Ruhong JiangRuhong Jiang1Chenyang Jiang Chenyang Jiang1*
  • 1Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang, Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 2Department of Nursing, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

A Corrigendum on
Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

by Ying, H., Yuan, H., Tang, X., Guo, W., Jiang, R., and Jiang, C. (2021). Front. Cardiovasc. Med. 8:641062. doi: 10.3389/fcvm.2021.641062

There is an error in the Funding statement. The correct number for Ruhong Jiang is 81900289. The correct number for Chenyang Jiang is 81970269. The updated statement appears below.

“This study was supported by a grant from the National Natural Science Foundation of China (grant no. 81900289 and 81970269). The funders played no role in the study design, data collection or analysis, manuscript preparation, or decision to publish.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: uric acid-lowering therapy, xanthine oxidase inhibitor, febuxostat, cardiovascular outcome, cardiovascular safety

Citation: Ying H, Yuan H, Tang X, Guo W, Jiang R and Jiang C (2021) Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 8:723626. doi: 10.3389/fcvm.2021.723626

Received: 11 June 2021; Accepted: 18 June 2021;
Published: 06 July 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Ying, Yuan, Tang, Guo, Jiang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chenyang Jiang, cyjiang@zju.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.